1. Home
  2. AMBA vs ARQT Comparison

AMBA vs ARQT Comparison

Compare AMBA & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambarella Inc.

AMBA

Ambarella Inc.

HOLD

Current Price

$86.78

Market Cap

3.6B

Sector

Technology

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$25.29

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMBA
ARQT
Founded
2004
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.5B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
AMBA
ARQT
Price
$86.78
$25.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
6
Target Price
$97.25
$34.00
AVG Volume (30 Days)
2.0M
1.4M
Earning Date
05-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
37.32
88.79
EPS
N/A
0.03
Revenue
$295,402,000.00
$376,072,000.00
Revenue This Year
$15.03
$34.85
Revenue Next Year
$12.41
$29.39
P/E Ratio
N/A
$881.00
Revenue Growth
N/A
91.34
52 Week Low
$48.30
$14.03
52 Week High
$96.69
$31.77

Technical Indicators

Market Signals
Indicator
AMBA
ARQT
Relative Strength Index (RSI) 61.15 47.36
Support Level $81.26 $24.96
Resistance Level $93.85 $27.99
Average True Range (ATR) 5.87 1.27
MACD 1.66 -0.25
Stochastic Oscillator 73.87 22.16

Price Performance

Historical Comparison
AMBA
ARQT

About AMBA Ambarella Inc.

Ambarella Inc is a developer of low-power system-on-a-chip, or SoC, semiconductors and software for edge and physical artificial intelligence (AI) applications and intelligent automation. Its products are used in a wide variety of human viewing, computer vision for edge and physical AI applications, including a variety of video security cameras, automotive camera systems, fixed robots, autonomous mobile robots (AMRs), industrial applications, intelligent transportation systems, and consumer devices, such as action, drone and 360 degree cameras. The company operates as a single operating and reportable segment and derives substantially all of its revenue from development and sales of low-power AI-based processing and video and image processing SoC solutions.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: